Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer (Q61920721)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer |
clinical trial |
Statements
A Phase 2 Study of GW786034 (Pazopanib) in Advanced Low-Grade or Intermediate-Grade Neuroendocrine Carcinoma (English)
0 references
March 2007
0 references
March 2014
0 references
52
0 references
21 year
0 references